ARRL member Eric Knight, KB1EHE, played a role in the development of an RF-based Alzheimer’s disease treatment that now shows great promise. A study published today in the Journal of Alzheimer’s Disease following a months-long FDA clinical trial of the treatment protocol concluded that memory decline in most patients “appeared to have been reversed to cognitive levels equivalent to 12 months ea...
Continue reading...
Continue reading...